Table 1.
Patient characteristics
| Variables | Group S (n = 23) | Group R (n = 24) | Group RD (n = 21) | p-value |
|---|---|---|---|---|
| Gender, n (%) | 0.158 | |||
| Male | 20 (86.96) | 16 (66.67) | 18 (85.71) | |
| Female | 3 (13.04) | 8 (33.33) | 3 (14.29) | |
| Age (years) | 66.00 (6.49) | 61.96 (7.94) | 61.43 (7.26) | 0.062 |
| ASA status | 0.970 | |||
| I | 8 (34.78) | 9 (37.50) | 8 (38.10) | |
| II | 15 (65.22) | 15 (62.50) | 13 (61.90) | |
| Weight (kg) | 59.91 (11.88) | 59.54 (9.70) | 60.76 (8.59) | 0.920 |
| Height (cm) | 167.65 (7.24) | 165.29 (7.47) | 166.76 (6.03) | 0.507 |
| BMI (kg/m2) | 21.19 (3.29) | 21.79 (3.35) | 21.77 (2.28) | 0.751 |
| Heart rate | 74.48 (10.83) | 72.33 (9.29) | 75.33 (15.84) | 0.692 |
| Mean arterial pressure (mmHg) | 94.00 (14.87) | 95.96 (9.96) | 102.24 (15.62) | 0.122 |
| SBP (mmHg) | 137.39 (25.84) | 135.92 (17.36) | 146.76 (24.79) | 0.242 |
| DBP (mmHg) | 72.83 (11.49) | 76.04 (9.47) | 80.05 (13.27) | 0.120 |
| Surgical site, n (%) | 0.099 | |||
| Esophagus | 21 (91.30) | 17 (70.83) | 19 (90.48) | |
| Lung | 2 (8.70) | 7 (29.17) | 2 (9.52) |
Notes: Data represent mean (SD). p < 0.05 is considered as a statistically significant difference. S, saline; R, 0.5% ropivacaine; RD, 5 mg dexamethasone and 0.5% ropivacaine.
Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index.